Ceramide-Enriched Membrane Domains Contribute to Targeted and Nontargeted Effects of Radiation through Modulation of PI3K/AKT Signaling in HNSCC Cells. 2020

Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
Laboratoire de Radiobiologie Cellulaire et Moléculaire, UMR CNRS 5822/IN2P3, IP2I, PRISME, Univ Lyon, Université Lyon 1, Faculté de Médecine Lyon-Sud, 69921 Oullins, France.

We investigated the potential involvement of ceramide-enriched membrane domains in radiation-induced targeted and nontargeted effects using head and neck squamous cell carcinoma with opposite radiosensitivities. In radiosensitive SCC61 cells, the proportion of targeted effects was 34% and nontargeted effects killed 32% of cells. In contrast, only targeted effects (30%) are involved in the overall death of radioresistant SQ20B cells. We then demonstrated in SCC61 cells that nontargeted cell response was driven by the formation of the radiation-induced ceramide-enriched domain. By contrast, the existence of these platforms in SQ20B cells confers a permissive region for phosphatidylinositol-3-kinase (PI3K)/AKT activation. The disruption of lipid raft results in strong inhibition of PI3K/AKT signaling, leading to radiosensitization and apparition of nontargeted effects. These results suggest that ceramide-enriched platforms play a significant role in targeted and nontargeted effects during radiotherapy and that drugs modulating cholesterol levels may be a good alternative for improving radiotherapy effectiveness.

UI MeSH Term Description Entries
D011827 Radiation Emission or propagation of acoustic waves (SOUND), ELECTROMAGNETIC ENERGY waves (such as LIGHT; RADIO WAVES; GAMMA RAYS; or X-RAYS), or a stream of subatomic particles (such as ELECTRONS; NEUTRONS; PROTONS; or ALPHA PARTICLES). Radiations
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002518 Ceramides Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE. Ceramide
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077195 Squamous Cell Carcinoma of Head and Neck The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer. HNSCC,Head And Neck Squamous Cell Carcinomas,Hypopharyngeal Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma,Oral Squamous Cell Carcinoma,Oral Squamous Cell Carcinomas,Oral Tongue Squamous Cell Carcinoma,Oropharyngeal Squamous Cell Carcinoma,Squamous Cell Carcinoma of Larynx,Squamous Cell Carcinoma of the Larynx,Squamous Cell Carcinoma of the Mouth,Squamous Cell Carcinoma of the Nasal Cavity,Carcinoma, Squamous Cell of Head and Neck,Head and Neck Squamous Cell Carcinoma,Squamous Cell Carcinoma of the Head and Neck,Squamous Cell Carcinoma, Head And Neck
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
April 2000, Archives of biochemistry and biophysics,
Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
January 2009, Biochimica et biophysica acta,
Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
January 2007, Progress in lipid research,
Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
January 2021, Methods in molecular biology (Clifton, N.J.),
Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
January 2008, Sub-cellular biochemistry,
Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
November 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
March 2019, Cancer chemotherapy and pharmacology,
Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
March 2023, Polymers,
Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
December 2019, The international journal of biochemistry & cell biology,
Riad Ladjohounlou, and Safa Louati, and Alexandra Lauret, and Arnaud Gauthier, and Dominique Ardail, and Nicolas Magne, and Gersende Alphonse, and Claire Rodriguez-Lafrasse
May 2020, European review for medical and pharmacological sciences,
Copied contents to your clipboard!